 |
|
|
| |
Renal Safety Profile of STB in Virologically Suppressed Subjects From Two Randomized, Phase 3b Switch Trials
|
| |
| |
Reported by Jules Levin
HIV Drug Therapy
November 2-6, 2014
Glasgow, UK
I Reeves1, M Fisher2, S Kegg3, J Arribas4, L Dau5, W Garner5, I Walker5, T Nguyen5
1Homerton University Hospital, London, UK; 2Brighton and Sussex University Hospital National Health Service Trust, Brighton, UK;
3Queen Elizabeth Hospital, London, UK; 4Hospital Universitario La Paz, Madrid, Spain; 5Gilead Sciences, Inc., Foster City, CA, USA
|
| |
|
|
|
|
|
